In recent trading, shares of NetApp, Inc. (Symbol: NTAP) have crossed above the average analyst 12-month target price of $100.14, changing hands for $100.94/share. When a stock reaches the target ...

CRISPR Therapeutics (NASDAQ:CRSP) stock has been slowly heading lower ... is proposing a new technology add-on payment (NTAP) of 75% for the CRISPR SCD and beta-thalassemia treatments.

The most recent trading session ended with NetApp (NTAP) standing at $99.42, reflecting a +1.89% shift from the previouse trading day's closing. The stock outpaced the S&P 500's daily gain of 1.2%.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...